Hakutulokset - Olaf Witt

Tarkenna hakua
  1. 1
    HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities

    HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities Tekijä E Koeneke, Olaf Witt, Ina Oehme

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    MAPK pathway activation in pilocytic astrocytoma

    MAPK pathway activation in pilocytic astrocytoma Tekijä David Jones, Jan Gronych, Peter Lichter, Olaf Witt, Stefan M. Pfister

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin

    Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin Tekijä Olaf Witt, Sven Mönkemeyer, Gabi Rönndahl, Bernhard Erdlenbruch, Dirk Reinhardt, Katrin Kanbach, Arnulf Pekrun

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    The enzyme activity of histone deacetylase 8 is modulated by a redox-switch

    The enzyme activity of histone deacetylase 8 is modulated by a redox-switch Tekijä Niklas Jänsch, Christian Meyners, Marius Muth, Aleksandra Kopranovic, Olaf Witt, Ina Oehme, Franz‐Josef Meyer‐Almes

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    HDAC8: a multifaceted target for therapeutic interventions

    HDAC8: a multifaceted target for therapeutic interventions Tekijä Alokta Chakrabarti, Ina Oehme, Olaf Witt, Guilherme Oliveira, Wolfgang Sippl, Christophe Romier, Raymond J. Pierce, Manfred Jung

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases

    Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases Tekijä Alokta Chakrabarti, Jelena Melesina, Fiona R. Kolbinger, Ina Oehme, Johanna Senger, Olaf Witt, Wolfgang Sippl, Manfred Jung

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells

    Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells Tekijä Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Dina ElHarouni, Ina Oehme, Olaf Witt, Till Milde, Jonas Ecker

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

    Histone Deacetylase 8 in Neuroblastoma Tumorigenesis Tekijä Ina Oehme, Hedwig E. Deubzer, Dennis Wegener, Diana Pickert, Jan-Peter Linke, Barbara Hero, Annette Kopp‐Schneider, Frank Westermann, Scott Ulrich, Andreas von Deimling, Matthias Fischer, Olaf Witt

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines

    Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines Tekijä Martin Michaelis, Malte Kleinschmidt, Susanne Barth, Florian Rothweiler, Janina Geiler, Rainer Breitling, Bernd Mayer, Hedwig E. Deubzer, Olaf Witt, Jörg Kreuter, Hans Wilhelm Doerr, Jaroslav Činátl, Jindřich Činátl

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

    Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival Tekijä Theresa Thole, Marco Lodrini, Johannes Fabian, Jasmin Wuenschel, Sebastian Pfeil, Thomas Hielscher, Annette Kopp‐Schneider, Ulrike Heinicke, Simone Fulda, Olaf Witt, Angelika Eggert, Matthias Fischer, Hedwig E. Deubzer

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated

    Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated Tekijä Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, Aubry K. Miller

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Pediatric low-grade glioma: State-of-the-art and ongoing challenges

    Pediatric low-grade glioma: State-of-the-art and ongoing challenges Tekijä Jason Fangusaro, David Jones, Roger J. Packer, David H. Gutmann, Till Milde, Olaf Witt, Sabine Mueller, Michael J. Fisher, Jordan R. Hansford, Uri Tabori, Darren Hargrave, Pratiti Bandopadhayay

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data

    Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data Tekijä Stephanie E. Combs, Kerstin A. Kessel, Klaus Herfarth, Alexandra Jensen, Susanne Oertel, Claudia Blattmann, Swantje Ecker, Angelika Hoess, Eike Martin, Olaf Witt, Oliver Jäkel, Andreas E. Kulozik, Jürgen Debus

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance

    Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance Tekijä Corinna Bingel, E Koeneke, Johannes Ridinger, Annika Bittmann, Martin Sill, Heike Peterziel, Jagoda K. Wrobel, I Rettig, Till Milde, Uta Fernekorn, Frank Weise, Andreas Schober, Olaf Witt, Ina Oehme

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance

    Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance Tekijä Johannes Ridinger, E Koeneke, Fiona R. Kolbinger, Katharina Koerholz, Siavosh Mahboobi, Lars Hellweg, Nikolas Gunkel, Aubry K. Miller, Heike Peterziel, Peter Schmezer, Anne Hamacher‐Brady, Olaf Witt, Ina Oehme

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma

    Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma Tekijä Markus Brockmann, Evon Poon, Teeara Berry, Anne Carstensen, Hedwig E. Deubzer, Lukas Rycak, Yann Jamin, Khin Thway, Simon P. Robinson, Frederik Roels, Olaf Witt, Matthias Fischer, Louis Chesler, Martin Eilers

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

    HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth Tekijä Till Milde, Ina Oehme, Andrey Korshunov, Annette Kopp‐Schneider, Marc Remke, Paul A. Northcott, Hedwig E. Deubzer, Marco Lodrini, Michael D. Taylor, Andreas von Deimling, Stefan M. Pfister, Olaf Witt

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients

    Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients Tekijä Christin Schmidt, Nil A. Schubert, Sebastian Brabetz, Norman Mack, Benjamin Schwalm, Jennifer A. Chan, Florian Selt, Christel Herold‐Mende, Olaf Witt, Till Milde, Stefan M. Pfister, Andrey Korshunov, Marcel Kool

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

    Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation Tekijä I Rettig, E Koeneke, Franziska Trippel, Wolf Mueller, Jürgen Burhenne, Annette Kopp‐Schneider, Johannes Fabian, Andreas Schober, Uta Fernekorn, Andreas von Deimling, Hedwig E. Deubzer, Till Milde, Olaf Witt, Ina Oehme

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors

    Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors Tekijä Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md. Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal, Alexander Kühn, Mark Hartmann, Dieter Weichenhan, Manfred Jung, Christoph Plass

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: